| Treatment outcomes of sorafenib for first line or cytokinerefractory advanced ... - UroToday |
|
|
UroTodayThe objective of the present study was to document the treatment efficacy and safety of sorafenib in Japanese patients with advanced renal cellcarcinoma ... read more |